2013•World Clinical DrugsRequires access

Comparative evaluation of four drugs in the treatment of Alzheimer's disease

Guo Zhen-rong

Abstract

Currently,donepezil,rivastigmine,galantamine and memantine are the first-line drugs in the treatment of Alzheimer's disease(AD).They have definite efficacy and can effectively improve the symptoms of AD patients with good safety and tolerability.This review describes those four drugs in terms of treatment effectiveness,safety/tolerability,market and development.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Tolerability, Rivastigmine, Galantamine, Donepezil, Medicine, Memantine, Disease, Intensive care medicine